|
|
2023年 欧文
1) Furuta
M, Sato M, Kasahara H, Tsukagoshi S, Hirayanagi K, Fujita Y, Takai E, Aihara Y,
Okamoto K, Ikeda Y. Clinical, radiological, and molecular analyses of neuronal
intranuclear inclusion disease with polyglycine inclusions. J Neurol Sci. 2023;
448: 120618.
2) Hashimoto
K, Nakamura T, Fujita Y, Furuta M, Makioka K, Shimoda Y, Iizuka T, Ikeda Y.
Coupling of Cortical Hyperintense Signals and Increased Glucose Metabolism in a
Case of Anti-GABAA Receptor Antibody-associated Encephalitis. Intern
Med. 2023; 62(23): 3545-3548.
3) Ishizawa
K, Fujita Y, Nagashima K, Nakamura T, Shibata M, Kasahara H, Makioka K,
Taketomi-Takahashi A, Hirasawa H, Higuchi T, Tsushima Y, Ikeda Y. Striatal
dopamine transporter binding differs between dementia with Lewy bodies and
Parkinson’s disease with dementia. J Neurol Sci. 2023; 451: 120713.
4) Ishizawa
K, Iwasaki O, Oka H, Sugawara T, Amari M, Kawarabayashi T, Okamoto K, Kaneko K,
Takahashi T, Ikeda Y, Takatama M, Shoji M. Two cases of unilateral cortical
fluid-attenuated inversion recovery-hyperintense lesions in anti-myelin
oligodendrocyte glycoprotein-associated encephalitis with seizures (FLAMES).
Clin Exp Neuroimmunol. 2023; 14: 133–137.
5) Kasahara
H, Ikeda M, Ikeda Y. The relationship between amyloid-β accumulation and
cerebrovascular disease in Alzheimer’s disease: role of amyloid positron
emission tomography. Vas-Cog Journal (Japanese Society of Vascular Cognitive
Impairment). 2023; 9: 5-8.
6) Kawarabayashi T, Nakamura
T, Miyashita K, Segawa T, Fukamachi I, Sugawara T, Oka H, Ishizawa K, Amari M,
Kasahara H, Makioka K, Ikeda Y, Takatama M, Shoji M. Clinical Evaluation of
Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients
with Alzheimer's Disease or Other Neurological Diseases. J Alzheimers Dis.
2023; 96(4): 1623-1638.
7) Nakamura
R, Tohnai G, Nakatochi M, Atsuta N, Watanabe H, Ito D, Katsuno M, Hirakawa A,
Izumi Y, Morita M, Hirayama T, Kano O, Kanai K, Hattori N, Taniguchi A, Suzuki
N, Aoki M, Iwata I, Yabe I, Shibuya K, Kuwabara S, Oda M, Hashimoto R, Aiba I,
Ishihara T, Onodera O, Yamashita T, Abe K, Mizoguchi K, Shimizu T, Ikeda Y,
Yokota T, Hasegawa K, Tanaka F, Nakashima K, Kaji R, Niwa JI, Doyu M, Terao C,
Ikegawa S, Fujimori K, Nakamura S, Ozawa F, Morimoto S, Onodera K, Ito T, Okada
Y, Okano H, Sobue G; Japanese Consortium for Amyotrophic Lateral Sclerosis
research (JaCALS) study group. Genetic factors affecting survival in Japanese
patients with sporadic amyotrophic lateral sclerosis: a genome-wide association
study and verification in iPSC-derived motor neurons from patients. J Neurol
Neurosurg Psychiatry. 2023; 94(10): 816-824.
8) Nakamura T, Kawarabayashi T, Nakahata N, Itoh K, Ihara K, Nakaji S, Ikeda
Y, Takatama M, Shoji M. Annual stability of the plasma Aß40/42 ratio and
associated factors. Ann Clin Transl Neurol. 2023; 10(6): 879-891.
9) Nakamura
T, Kawarabayashi T, Ueda T, Shimomura S, Hoshino M, Itoh K, Ihara K, Nakaji S,
Takatama M, Ikeda Y, Shoji M. Plasma ApoE4 Levels Are Lower than ApoE2 and
ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of
Amyloid-β Amyloidosis in Alzheimer's Disease. J Alzheimers Dis. 2023; 93(1):
333-348. .
10) Saito
M, Uchiyama A, Kim J, Endo Y, Yasuda M, Aoki S, Ikeda Y, Nishino I, Motegi SI.
Case report of anti-survival motor neuron complex antibody-positive overlap
syndrome of diffuse cutaneous systemic sclerosis and idiopathic inflammatory
myopathies. J Dermatol. 2023; Epub ahead of print. PMID: 38149379.
11) Shibata
M, Makioka K, Nakamura T, Kasahara H, Yamazaki T, Takatama M, Okamoto K, Ikeda
Y. Role of complement activation and disruption of the blood-brain barrier in
the pathogenesis of multiple system atrophy. Neurosci Lett. 2024; 822: 137642.
|
